|
|
Article: FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine.
- Article from:
- Business Wire
- Article date:
- December 10, 2007
|
Copyright informationCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- The Federal Drug Administration announced Friday approval of a Phase 1 clinical trial designed to study a breast cancer vaccine developed at the Sidney Kimmel Cancer Center (http://www.skcc.org).
According to SKCC President and CEO Dr. Albert Deisseroth, "This vaccine will be administered for recurrent breast cancer and is the first cancer vaccine to be specifically designed for the aged immune system which often fails to respond to vaccinations for infectious diseases as well as cancer."
"If the vaccine is able to suppress the growth of established breast cancer, it is very likely that it will be of use in preventing the development of breast cancer in ...